Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.